Super bioavailable itraconazole and its place and relevance in recalcitrant dermatophytosis: Revisiting skin levels of itraconazole and minimum inhibitory concentration data
Itraconazole, is the most commonly prescribed oral antifungal agent in India, and has a low minimum inhibitory concentration as compared to other oral antifungals, and in conjunction with the markedly high skin levels, the drug should have a predictably good clinical response which is not the consis...
Saved in:
Main Authors: | Kabir Sardana (Author), Sinu Rose Mathachan (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis
by: Dhiraj Dhoot, et al.
Published: (2023) -
Super bioavailable (SUBA) itraconazole-induced galactorrhea-could it be due to hydroxypropyl methylcellulose phthalate?
by: Sheetal Yadav, et al.
Published: (2024) -
An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India
by: Shenoy M, et al.
Published: (2021) -
A randomized control study of oral itraconazole versus itraconazole with terbinafine in the treatment of dermatophytosis
by: Divya Sharma, et al.
Published: (2023) -
Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial
by: Shenoy MM, et al.
Published: (2023)